Australia Radiodermatitis Market Size & Outlook, 2023-2030

The radiodermatitis market in Australia is expected to reach a projected revenue of US$ 20.3 million by 2030. A compound annual growth rate of 4.4% is expected of Australia radiodermatitis market from 2024 to 2030.

Revenue, 2023 (US$M)
$15.0
Forecast, 2030 (US$M)
$20.3
CAGR, 2024 - 2030
4.4%
Report Coverage
Australia

Australia radiodermatitis market highlights

  • The Australia radiodermatitis market generated a revenue of USD 15.0 million in 2023 and is expected to reach USD 20.3 million by 2030.
  • The Australia market is expected to grow at a CAGR of 4.4% from 2024 to 2030.
  • In terms of segment, topical was the largest revenue generating product in 2023.
  • Topical is the most lucrative product segment registering the fastest growth during the forecast period.


Radiodermatitis market data book summary

Market revenue in 2023USD 15.0 million
Market revenue in 2030USD 20.3 million
Growth rate4.4% (CAGR from 2023 to 2030)
Largest segmentTopical
Fastest growing segmentTopical
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOral, Topical, Dressings
Key market players worldwideSmith & Nephew PLC, Integra LifeSciences, ConvaTec Group PLC, 3M Co, Molnlycke Health Care, Alliqua BioMedical, Stratpharma, BMG Pharma


Other key industry trends

  • In terms of revenue, Australia accounted for 3.5% of the global radiodermatitis market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China radiodermatitis market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 51.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Radiodermatitis Market Scope

Radiodermatitis market segmentation & scope
Oral
Corticosteroids
Hydrophilic Creams
Antibiotics
Others
Hydrogel & Hydrocolloid Dressing
No sting barrier films
Honey Impregnated Gauze
Silicone Coated Dressings
Others
Hospital Pharmacy
Retail Pharmacy
Online Store

Radiodermatitis Market Companies

Name Profile # Employees HQ Website

Australia radiodermatitis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiodermatitis market will help companies and investors design strategic landscapes.


Topical was the largest segment with a revenue share of 71.33% in 2023. Horizon Databook has segmented the Australia radiodermatitis market based on oral, topical, dressings covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Australia radiodermatitis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia radiodermatitis market databook

  • Our clientele includes a mix of radiodermatitis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia radiodermatitis market , including forecasts for subscribers. This country databook contains high-level insights into Australia radiodermatitis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia radiodermatitis market size, by product, 2018-2030 (US$M)

Australia Radiodermatitis Market Outlook Share, 2023 & 2030 (US$M)

Australia radiodermatitis market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more